Table 2.
COVID-19 clinical presentation and symptoms
| All patients (n=200) | Hospitalised (n=152) | Not hospitalised (n=48) | |
|---|---|---|---|
| Symptoms | |||
| Fever (>37·5°C) | 127/198 (64%) | 104/150 (69%) | 23 (48%) |
| Dyspnoea | 106/198 (54%) | 89/150 (59%) | 17 (35%) |
| Cough | 103/198 (52%) | 83/150 (55%) | 20 (42%) |
| Fatigue | 54/198 (27%) | 46/150 (31%) | 8 (17%) |
| Headache | 13/198 (7%) | 10/150 (7%) | 3 (6%) |
| Diarrhoea | 10/198 (5%) | 10/150 (7%) | 0 |
| Myalgia | 10/198 (5%) | 9/150 (6%) | 1 (2%) |
| Nasal congestion | 6/198 (3%) | 5/150 (3%) | 1 (2%) |
| Anosmia* | 7/198 (4%) | 4/150 (3%) | 3 (6%) |
| Dysgeusia | 7/198 (4%) | 4/150 (3%) | 3 (6%) |
| Loss of smell or taste* | 6/198 (3%) | 4/150 (3%) | 2 (4%) |
| Shivers | 4/198 (2%) | 4/150 (3%) | 0 |
| Conjunctival congestion | 1/198 (1%) | 0/150 | 1 (2%) |
| Otitis | 0/198 | 0/150 | 0 |
| Other | 19/198 (10%) | 17/150 (11%) | 2 (4%) |
| None (asymptomatic) | 24/198 (12%) | 9/150 (6%) | 15 (31%) |
| Diagnostic test | |||
| RT-PCR | 180/198 (91%) | 140/150 (93%) | 40 (83%) |
| Clinical findings | 5/198 (3%) | 2/150 (1%) | 3 (6%) |
| Radiological findings | 13/198 (7%) | 8/150 (5%) | 5 (11%) |
| Complications | |||
| Any complications | 143/157 (91%) | 123/127 (97%) | 20/30 (67%) |
| Pneumonia or pneumonitis | 125/157 (80%) | 90/127 (71%) | 16/30 (53%) |
| Acute respiratory distress syndrome | 42/157 (27%) | 40/127 (31%) | 2/30 (7%) |
| Multi-organ failure | 12/157 (8%) | 11/127 (9%) | 1/30 (3%) |
| Sepsis | 8/157 (5%) | 7/127 (6%) | 1/30 (3%) |
| Coagulopathy | 8/157 (5%) | 8/127 (6%) | 0/30 |
| Bacterial infection | 6/157 (4%) | 6/127 (5%) | 0/30 |
| Arrhythmia | 3/157 (2%) | 3/127 (2%) | 0/30 |
| Heart failure | 1/157 (1%) | 1/127 (1%) | 0/30 |
| Other | 15/157 (10%) | 12/127 (9%) | 3/30 (10%) |
| No complications | 14/157 (9%) | 4/127 (3%) | 10/30 (33%) |
*
Data obtained as two separate questions.